-transparent.png){kind=logo}
The hydrosoluble triazene derivatives of phenylacetic, phenylbutyric and cinnamic acid have been synthesized and their logP and pKa values were simultaneously determined according to a multiparametric fitting of potentiometric data. The antitumor activity caused by the synthesized compounds in mice bearing either Lewis lung carcinoma or TLX5 lymphoma was evaluated and discussed in comparison with the parent compound (p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (DM-COOK, CAS 70055-49-1). The tested compounds were at least as active as DM-COOK, the cinnamic and the phenylacetic derivatives being the more active compounds in mice bearing TLX5 lymphoma and Lewis lung carcinoma, respectively.
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
May 1986,
Pharmacological research communications,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
January 1984,
Cancer chemotherapy and pharmacology,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
January 1980,
Journal of pharmaceutical sciences,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
November 1982,
Cancer treatment reports,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
February 1984,
European journal of cancer & clinical oncology,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
September 1985,
Methods and findings in experimental and clinical pharmacology,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
March 1978,
Journal of medicinal chemistry,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
January 1984,
Cancer research,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
January 1989,
Cancer chemotherapy and pharmacology,
A Varnavas, and
C Nisi, and
L Lassiani, and
G Sava, and
L Perissin, and
E Boccù
December 1985,
Journal of chromatography,
